XML 29 R16.htm IDEA: XBRL DOCUMENT
v3.21.2

Earnings per Common Share | 6 Months Ended
--- | ---
Jun. 30, 2021
Earnings Per Share [Abstract] |
Earnings per Common Share | Earnings per Common Share The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Basic: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 142.3 |  |  | $ | 48.2 |  |  | $ | 275.1 |  |  | $ | 157.0 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (28.7) |  |  | (14.8) |  |  | (54.2) |  |  | (36.5) |
Less: Income allocated to participating securities | (0.5) |  |  | — |  |  | (1.0) |  |  | (0.4) |
Income from continuing operations attributable to Encompass Health common shareholders | 113.1 |  |  | 33.4 |  |  | 219.9 |  |  | 120.1 |
(Loss) income from discontinued operations, net of tax, attributable to Encompass Health common shareholders | (0.3) |  |  | 0.1 |  |  | (0.3) |  |  | — |
Net income attributable to Encompass Health common shareholders | $ | 112.8 |  |  | $ | 33.5 |  |  | $ | 219.6 |  |  | $ | 120.1 |
Denominator: |  |  |  |  |  |  |
Basic weighted average common shares outstanding | 99.0 |  |  | 98.7 |  |  | 99.0 |  |  | 98.5 |
Basic earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 1.14 |  |  | $ | 0.34 |  |  | $ | 2.22 |  |  | $ | 1.22 |
Discontinued operations | — |  |  | — |  |  | — |  |  | — |
Net income | $ | 1.14 |  |  | $ | 0.34 |  |  | $ | 2.22 |  |  | $ | 1.22 |
Diluted: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 142.3 |  |  | $ | 48.2 |  |  | $ | 275.1 |  |  | $ | 157.0 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (28.7) |  |  | (14.8) |  |  | (54.2) |  |  | (36.5) |
Income from continuing operations attributable to Encompass Health common shareholders | 113.6 |  |  | 33.4 |  |  | 220.9 |  |  | 120.5 |
(Loss) income from discontinued operations, net of tax, attributable to Encompass Health common shareholders | (0.3) |  |  | 0.1 |  |  | (0.3) |  |  | — |
Net income attributable to Encompass Health common shareholders | $ | 113.3 |  |  | $ | 33.5 |  |  | $ | 220.6 |  |  | $ | 120.5 |
Denominator: |  |  |  |  |  |  |
Diluted weighted average common shares outstanding | 100.2 |  |  | 99.9 |  |  | 100.2 |  |  | 99.6 |
Diluted earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 1.13 |  |  | $ | 0.34 |  |  | $ | 2.20 |  |  | $ | 1.21 |
Discontinued operations | — |  |  | — |  |  | — |  |  | — |
Net income | $ | 1.13 |  |  | $ | 0.34 |  |  | $ | 2.20 |  |  | $ | 1.21 |
The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Basic weighted average common shares outstanding | 99.0 |  |  | 98.7 |  |  | 99.0 |  |  | 98.5 |
Restricted stock awards, dilutive stock options, and restricted stock units | 1.2 |  |  | 1.2 |  |  | 1.2 |  |  | 1.1 |
Diluted weighted average common shares outstanding | 100.2 |  |  | 99.9 |  |  | 100.2 |  |  | 99.6 |
See Note 17, Earnings per Common Share, to the consolidated financial statements accompanying the 2020 Form 10‑K for additional information related to our common stock.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration